$5.20
0.14[2.77%]
Last update: 8:50AM Get Real Time Here
Moleculin Biotech
(NASDAQ:MBRX)Moleculin Biotech Stock (NASDAQ:MBRX), Earnings Estimates, EPS, and Revenue
Moleculin Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 13
EPS Estimate
$-3.530
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Moleculin Biotech using advanced sorting and filters.
No data available to display
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|
FAQ
When is Moleculin Biotech (NASDAQ:MBRX) reporting earnings?
Moleculin Biotech (MBRX) is scheduled to report earnings on May 13, 2024. The last reported earnings were for reported on March 22, 2024 for Q4.
What were the latest earnings per share (EPS) for Moleculin Biotech (NASDAQ:MBRX)?
The Actual EPS was $-5.09, which missed the estimate of $-3.05.
What were Moleculin Biotech’s (NASDAQ:MBRX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.